Tor Molden

Predicting CIN2+ when detecting HPV mRNA and DNA by PreTect HPV‐proofer and consensus PCR: A 2‐year follow‐up of women with ASCUS or LSIL pap smear

Tor Molden, Jan F. Nygård, Irene Kraus et al. · International Journal of Cancer · 2005 · 153 citations · Full text

Viral Diagnostics, Pathology, Gynecology +23

Comparison of Human Papillomavirus Messenger RNA and DNA Detection: A Cross-sectional Study of 4,136 Women >30 Years of Age with a 2-Year Follow-up of High-Grade Squamous Intraepithelial Lesion

Tor Molden, Irene Kraus, Frank Karlsen et al. · Cancer Epidemiology Biomarkers & Prevention · 2005 · 145 citations

Presence of E6 and E7 mRNA from Human Papillomavirus Types 16, 18, 31, 33, and 45 in the Majority of Cervical Carcinomas

Irene Kraus, Tor Molden, Ruth Holm et al. · Journal of Clinical Microbiology · 2006 · 123 citations · Full text

PreTect™ HPV-Proofer: Real-time detection and typing of E6/E7 mRNA from carcinogenic human papillomaviruses

Tor Molden, Irene Kraus, Hanne Skomedal et al. · Journal of Virological Methods · 2007 · 92 citations

Diagnostic Virology, Viral Diagnostics, Human Papillomavirus Vaccines +11

Human papillomavirus E6/E7 mRNA expression in women younger than 30 years of age

Tor Molden, Irene Kraus, Frank Karlsen et al. · Gynecologic Oncology · 2005 · 75 citations

Cervical Cancer, Human Papillomavirus Vaccines, Pathology +3